The Safety of Using Buprenorphine With Naloxone in a Buccal Film to Initiate Treatment of Opioid Dependent Subjects

NCT02516436 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped FDA did not require a clinical trial for indication.

Conditions

Opioid Dependence

Interventions

DRUG: BEMA Buprenorphine NX
DRUG: Buprenorphine

Sponsor

BioDelivery Sciences International